Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis

British Journal of Surgery

Volumn 83, Issue 3, 1996, Pages 349-353

  De Beaux, A C ^a   Goldie, A S ^a   Ross, J A ^a   Carter, D C ^a   Fearon, K C H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ACUTE PANCREATITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INTERLEUKIN-6; MULTIPLE ORGAN FAILURE; PANCREATITIS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029992055     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830317     Document Type: Article

References (29)

1. de Beaux AC, Palmer KR, Carter DC. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995; 37: 121-6.
2. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988; 3: 105-12.
3. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269: 1829-35.
4. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975-8.
5. Michie HR, Manogue KR, Spriggs DR et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-6.
6. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor α. Cytokine 1991; 3: 12-16.
7. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33: 1126-8.
8. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autorine control of inflammatory responses. J Cell Biol 1988; 107: 1269-77.
9. Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA. Detection of tumour necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 1993; 167: 1344-50.
10. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
11. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992; 90: 533-6.
12. Viedma JA, Pérex-Mateo M, Domínguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264-7.
13. Leser H-G, Gross V, Scheibenbrogen C et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenteroloy 1991; 101: 782-5.
14. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-5.
15. Mayer AD, McMahon MJ, Bowen M, Cooper EH. C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol 1984; 37: 207-11.
16. 2 in the assessment of the severity of acute pancreatitis. Gut 1987; 28: 764-71.
17. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, untiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177-81.
18. Windsor JA, Fearon KCH, Ross JA et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 1993; 80: 1042-6.
19. Cerra FB. The hypermetabolism organ failure complex. World J Surg 1987; 11: 173-81.
20. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-34.
21. Bradley EL III. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128: 586-90.
22. Goris RJA, te Boekhorst TPA, Nuytinck JKS, Gimbrère JSF. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 1985; 120: 1109-15.
23. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56 (5 Suppl): S92-6.
24. Dofferhoff AS, Bom VJJ, de Vries-Hospers HG et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-92.
25. Hoch RC, Rodriguez R, Manning T et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21: 839-45.
26. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MRB. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81: 1306-8.
27. Barie PS, Tahamont MV, Malik AB. Prevention of increased pulmonary vascular permeability after pancreatitis by granulocyte depletion in sheep. Am Rev Respir Dis 1982; 126: 904-8.
28. Tran DD, Cuesta MA. Evaluation of severity in patients with acute pancreatitis. Am J Gastroenterol 1992; 87: 604-8.
29. Rinderknecht H. Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 1994; 16: 11-15.